Access this stock data via API
Subscribe
Edwards Lifesciences Corporation
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 4.6B 6.0B 5.4B 5.2B
Cost of revenue 952.4M 1.4B 1.1B 1.2B
Gross profit 3.7B 4.6B 4.3B 4.0B
Operating expense
Research & development 897.4M 1.1B 945.2M 903.1M
Selling general and admin 1.5B 1.8B 1.6B 1.5B
Other operating expenses -255.7K
Operating income 1.3B 1.7B 1.8B 1.6B
Non operating interest income
Income 102.5M 67.2M 35.5M 17.4M
Expense 16.9M 17.6M 19.2M 18.4M
Other income expense -27.7M -180.1M -38.1M 116.2M
Pretax income 1.3B 1.6B 1.8B 1.7B
Tax provision 129.6M 198.7M 245.5M 198.9M
Net income 3.6B 1.4B 1.5B 1.5B
Basic EPS 7.0 2.3 2.5 2.4
Diluted EPS 7.0 2.3 2.4 2.4
Basic average shares 509.4M 629.6M 644.2M 648.7M
Diluted average shares 509.4M 629.6M 644.2M 648.7M
EBITDA 1.5B 1.9B 2.0B 1.7B
Net income from continuing op. 3.6B 1.4B 1.5B 1.5B
Minority interests 4.9M 3M 0 0
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 1 hour 7 minutes

06:52
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).